Hsieh, Ming-Ju <br/><br/>
Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.  [electronic resource] 

 -  British journal of pharmacology  Jun 2014 
 - 3037-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5381 
<br/><br/><label>Standard No.: </label>10.1111/bph.12626  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Humans<br/>Isoflavones--pharmacology<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Matrix Metalloproteinase 9--genetics<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>NF-kappa B--metabolism<br/>Neoplasm Invasiveness<br/>Phenols--pharmacology<br/>Phosphorylation<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Transcription Factor AP-1--metabolism<br/>Transcription, Genetic--drug effects<br/>Transfection<br/>Xenograft Model Antitumor Assays